Texas A&M University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Texas A&M University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9301
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Texas A&M University (TAMU) is a research based university that provide educational and research services. The university offers undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences, College of Architecture, Mays Business School, Baylor College of Dentistry, College of Education and Human Development, engineering students testing a robotic device, Dwight Look College of Engineering, College of Geosciences and College of Veterinary Medicine and Biomedical Sciences, among others. TAMU also offers education in the field of law, liberal arts, medicine, public health and science, among others. The university provides undergraduate and graduate research programs. It operates in the US, Qatar, Mexico and Costa Rica. TAMU is headquartered in College Station, Texas, the US.

Texas A&M University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Texas A&M University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Texas A&M University, Medical Devices Deals, 2012 to YTD 2018 9
Texas A&M University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Texas A&M University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Texas A&M University and Greffex Sign Research Agreement 11
Texas A&M University Enters into Agreement with iBio 12
Licensing Agreements 13
Celltex Therapeutics Enters into Licensing Agreement with Texas A&M Institute for Regenerative Medicine 13
Xoma Enters into Licensing Agreement with Texas A&M University System 14
Texas A&M University – Key Competitors 15
Texas A&M University – Key Employees 16
Texas A&M University – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Apr 18, 2018: National Academies’ Gulf Research Program Awards Over $340,000 to Assist Scientific Research Impacted by Hurricanes Harvey and Irma 18
Mar 05, 2018: Texas A&M Chemists Use Technology to Decode Language of Lipid-Protein Interaction 20
Feb 26, 2018: CPRIT awards more than $2.6 million to Texas A&M 23
Jan 10, 2018: Texas A&M Research shows Biological Clocks Could Improve Brain Cancer Treatmen 24
Dec 27, 2017: Technical University of Munich: Double strike against tuberculosis 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Texas A&M University, Pharmaceuticals & Healthcare, Key Facts 2
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Texas A&M University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Texas A&M University, Deals By Therapy Area, 2012 to YTD 2018 8
Texas A&M University, Medical Devices Deals, 2012 to YTD 2018 9
Texas A&M University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Texas A&M University and Greffex Sign Research Agreement 11
Texas A&M University Enters into Agreement with iBio 12
Celltex Therapeutics Enters into Licensing Agreement with Texas A&M Institute for Regenerative Medicine 13
Xoma Enters into Licensing Agreement with Texas A&M University System 14
Texas A&M University, Key Competitors 15
Texas A&M University, Key Employees 16
Texas A&M University, Subsidiaries 17

List of Figures
Texas A&M University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Texas A&M University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Texas A&M University, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Texas A&M University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medidata Solutions Inc (MDSO)-医療機器分野:企業M&A・提携分析
    Summary Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data & analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analy …
  • Yakult Honsha Co Ltd (2267):製薬・医療:M&Aディール及び事業提携情報
    Summary Yakult Honsha Co Ltd (Yakult) is a probiotics company that undertakes the development, manufacture and commercialization of probiotic and pharmaceutical products. The company’s product portfolio encompasses food and beverages such as fermented milk drinks, juice and others products; pharmace …
  • The AES Corporation:企業の戦略・SWOT・財務分析
    The AES Corporation - Strategy, SWOT and Corporate Finance Report Summary The AES Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ams AG (AMS):企業の財務・戦略的SWOT分析
    Summary ams AG (ams), formerly austriamicrosystems AG is a technology company that manufactures and markets semiconductor products. The company's products comprise audio systems, environmental sensors, light sensors, smart light management, spectral sensing, CMOS imaging sensors, medical imaging and …
  • Keyence Corporation:企業の戦略・SWOT・財務分析
    Keyence Corporation - Strategy, SWOT and Corporate Finance Report Summary Keyence Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • eTheRNA Immunotherapies NV:製薬・医療:M&Aディール及び事業提携情報
    Summary ETheRNA Immunotherapies NV (eTheRNA) is a developer of novel immunotherapies for the treatment of cancers and infectious diseases. The company’s pipeline products include mRNA-based immunotherapies for various indications such as melanoma, triple negative breast cancer and infectious disease …
  • Vingroup Joint Stock Co:企業の戦略・SWOT・財務分析
    Vingroup Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vingroup Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SpectraCure AB:製薬・医療:M&Aディール及び事業提携情報
    Summary SpectraCure AB (SpectraCure) is a provider of cancer treatment solutions that offers medical device systems containing laser light sources and photoreactive drugs. The company develops and therapy system, commercializes photodynamic with IDOSE for tumors. It provides IDOSE platform which all …
  • Wave 80 Biosciences Inc:企業の製品パイプライン分析2018
    Summary Wave 80 Biosciences Inc (Wave 80) is a medical device company that develops molecular diagnostic instruments and consumables. The company develops molecular diagnostics instruments for chlamydia, respiratory illness, cancers, autoimmune diseases, hepatitis B, hepatitis C, HIV/AIDS and other …
  • juwi AG:電力:M&Aディール及び事業提携情報
    Summary juwi AG (juwi) a subsidiary of MVV Energie AG, is a renewable energy company that offers project development and engineering procurement and construction services; and products and solutions for the energy turnaround. It offers whole-scale project development services for the planning and co …
  • Hess Corp (HES):電力:M&Aディール及び事業提携情報
    Summary Hess Corp (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, the Joint Development Area of Malaysia/Thailand (JDA), and Malaysia. It offers fee-based services including gathering, …
  • Bank Muscat:企業の戦略・SWOT・財務分析
    Bank Muscat - Strategy, SWOT and Corporate Finance Report Summary Bank Muscat - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Liechtensteinische Landesbank AG:企業の戦略・SWOT・財務情報
    Liechtensteinische Landesbank AG - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Foundation Medicine, Inc.:企業のM&A・事業提携・投資動向
    Foundation Medicine, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Foundation Medicine, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Hindustan Unilever Ltd (HINDUNILVR):企業の財務・戦略的SWOT分析
    Hindustan Unilever Ltd (HINDUNILVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • J.E. Dunn Construction Group Inc:企業の戦略的SWOT分析
    J.E. Dunn Construction Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • EuroSibEnergo Plc-エネルギー分野:企業M&A・提携分析
    Summary EuroSibEnergo PLC (EuroSibEnergo), a subsidiary of En+ Group is an energy company and producer of hydroelectric power. EuroSibEnergo generates, transmits and distributes electricity. It operations include extraction of coal, distribution and facilitating low cost operations. The company is e …
  • Scynexis Inc (SCYX):企業の財務・戦略的SWOT分析
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company provides pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis …
  • First Security Bank Inc:企業の戦略・SWOT・財務情報
    First Security Bank Inc - Strategy, SWOT and Corporate Finance Report Summary First Security Bank Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆